XBP1 and plasma cell myeloma: MKC-3946, a salicylaldehydes derivative, inhibits chemically induced XBP1 splicing in multiple myeloma cell lines as well as patient-derived samples without affecting IRE1α phosphorylation in this context (Mimura et al. 2012).